Acrolein but not its metabolite, 3-Hydroxypropylmercapturic acid (3HPMA), activates vascular transient receptor potential Ankyrin-1 (TRPA1): Physiological to toxicological implications.

MLA

Jin, L., et al. “Acrolein but Not Its Metabolite, 3-Hydroxypropylmercapturic Acid (3HPMA), Activates Vascular Transient Receptor Potential Ankyrin-1 (TRPA1): Physiological to Toxicological Implications.” Toxicology and Applied Pharmacology, vol. 426, Sept. 2021, p. 115647. EBSCOhost, https://doi.org/10.1016/j.taap.2021.115647.

APA

Jin, L., Lorkiewicz, P., Xie, Z., Bhatnagar, A., Srivastava, S., & Conklin, D. J. (2021). Acrolein but not its metabolite, 3-Hydroxypropylmercapturic acid (3HPMA), activates vascular transient receptor potential Ankyrin-1 (TRPA1): Physiological to toxicological implications. Toxicology and Applied Pharmacology, 426, 115647. https://doi.org/10.1016/j.taap.2021.115647

Chicago

Jin, L, P Lorkiewicz, Z Xie, A Bhatnagar, S Srivastava, and D J Conklin. 2021. “Acrolein but Not Its Metabolite, 3-Hydroxypropylmercapturic Acid (3HPMA), Activates Vascular Transient Receptor Potential Ankyrin-1 (TRPA1): Physiological to Toxicological Implications.” Toxicology and Applied Pharmacology 426 (September): 115647. doi:10.1016/j.taap.2021.115647.